Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Jan 17;12(1):e0169548.
doi: 10.1371/journal.pone.0169548. eCollection 2017.

Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis

Charlotte Beaudart  1 , Myriam Zaaria  2 , Françoise Pasleau  3 , Jean-Yves Reginster  1 , Olivier Bruyère  1
Affiliations
Meta-Analysis

Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis

Charlotte Beaudart et al. PLoS One. .

Abstract

Objective: The purpose of this study was to perform a systematic review to assess the short-, middle- and long-term consequences of sarcopenia.

Methods: Prospective studies assessing the consequences of sarcopenia were searched across different electronic databases (MEDLINE, EMBASE, EBM Reviews, Cochrane Database of Systematic Reviews, EBM Reviews ACP Journal Club, EBM Reviews DARE and AMED). Only studies that used the definition of the European Working Group on Sarcopenia in Older People to diagnose sarcopenia were included. Study selection and data extraction were performed by two independent reviewers. For outcomes reported by three or more studies, a meta-analysis was performed. The study results are expressed as odds ratios (OR) with 95% CI.

Results: Of the 772 references identified through the database search, 17 were included in this systematic review. The number of participants in the included studies ranged from 99 to 6658, and the duration of follow-up varied from 3 months to 9.8 years. Eleven out of 12 studies assessed the impact of sarcopenia on mortality. The results showed a higher rate of mortality among sarcopenic subjects (pooled OR of 3.596 (95% CI 2.96-4.37)). The effect was higher in people aged 79 years or older compared with younger subjects (p = 0.02). Sarcopenia is also associated with functional decline (pooled OR of 6 studies 3.03 (95% CI 1.80-5.12)), a higher rate of falls (2/2 studies found a significant association) and a higher incidence of hospitalizations (1/1 study). The impact of sarcopenia on the incidence of fractures and the length of hospital stay was less clear (only 1/2 studies showed an association for both outcomes).

Conclusion: Sarcopenia is associated with several harmful outcomes, making this geriatric syndrome a real public health burden.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Search strategy.
Fig 2
Fig 2
Mortality (A) and functional decline (B) as outcomes of sarcopenia.
See this image and copyright information in PMC

References

    1. Deschenes MR. Effects of aging on muscle fibre type and size. Sports Med. 2004;34: 809–24. - PubMed
    1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997/05/01. 1997;127: 990S–991S. - PubMed
    1. Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, Dynapenia, and the Impact of Advancing Age on Human Skeletal Muscle Size and Strength; a Quantitative Review. Front Physiol. 2012;3. - PMC - PubMed
    1. Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr. 2009;90: 1579–85. 10.3945/ajcn.2009.28047 - DOI - PMC - PubMed
    1. Manini TM, Clark BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci. 2012;67: 28–40. 10.1093/gerona/glr010 - DOI - PMC - PubMed

MeSH terms